Form 483

Milbar Laboratories, Inc. Form 483, 2024-11-07

FDA issued a Form 483 to Milbar Laboratories, Inc. on 2024-11-07 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

Milbar Laboratories, Inc. · East Haven, United States · Issued November 7, 2024

Overview

  • 7 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

7 Nov 2024
21 CFR 211.166(a)

Results not used for expiration dates, storage cond.

Cited by Samir C Gala, Daniel L Zheng

7 Nov 2024
21 CFR 211.166(a)

Written program not followed

Cited by Samir C Gala, Daniel L Zheng

7 Nov 2024
21 CFR 211.22(c)

Approve or reject procedures or specs

Cited by Samir C Gala, Daniel L Zheng

7 Nov 2024
21 CFR 211.42(a)

Buildings of Suitable Size, Construction, Location

Cited by Samir C Gala, Daniel L Zheng

7 Nov 2024
21 CFR 211.63

Equipment Design, Size and Location

Cited by Samir C Gala, Daniel L Zheng

Inspected site

MLMilbar Laboratories, Inc.East Haven, United States

Inspection team

DLDaniel L Zheng

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.166(a)Cited across public-safe Form 483 observations2x
21 CFR 211.22(c)Cited across public-safe Form 483 observations1x
21 CFR 211.42(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere